AU535804B2 - Influenza vaccine production - Google Patents

Influenza vaccine production

Info

Publication number
AU535804B2
AU535804B2 AU58244/80A AU5824480A AU535804B2 AU 535804 B2 AU535804 B2 AU 535804B2 AU 58244/80 A AU58244/80 A AU 58244/80A AU 5824480 A AU5824480 A AU 5824480A AU 535804 B2 AU535804 B2 AU 535804B2
Authority
AU
Australia
Prior art keywords
influenza vaccine
vaccine production
production
influenza
vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU58244/80A
Other versions
AU5824480A (en
Inventor
Karen K. Brown
Richard C. Stewart
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Corp
Original Assignee
Cutter Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21904398&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU535804(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Cutter Laboratories Inc filed Critical Cutter Laboratories Inc
Publication of AU5824480A publication Critical patent/AU5824480A/en
Application granted granted Critical
Publication of AU535804B2 publication Critical patent/AU535804B2/en
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
AU58244/80A 1979-05-15 1980-05-09 Influenza vaccine production Expired AU535804B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3923679A 1979-05-15 1979-05-15
US039236 1979-05-15

Publications (2)

Publication Number Publication Date
AU5824480A AU5824480A (en) 1980-11-20
AU535804B2 true AU535804B2 (en) 1984-04-05

Family

ID=21904398

Family Applications (1)

Application Number Title Priority Date Filing Date
AU58244/80A Expired AU535804B2 (en) 1979-05-15 1980-05-09 Influenza vaccine production

Country Status (13)

Country Link
EP (1) EP0019218B2 (en)
JP (1) JPS55153723A (en)
AR (1) AR220838A1 (en)
AT (1) ATE16454T1 (en)
AU (1) AU535804B2 (en)
CA (1) CA1122527A (en)
DE (1) DE3071225D1 (en)
DK (1) DK154749C (en)
ES (1) ES491517A0 (en)
IL (1) IL60063A0 (en)
NO (1) NO801443L (en)
RO (1) RO79525B (en)
YU (1) YU41923B (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5753489A (en) * 1994-11-10 1998-05-19 Immuno Ag Method for producing viruses and vaccines in serum-free culture
US5698433A (en) * 1994-11-10 1997-12-16 Immuno Ag Method for producing influenza virus and vaccine
ATE542891T1 (en) * 1994-11-10 2012-02-15 Baxter Healthcare Sa METHOD FOR PRODUCING BIOLOGICAL PRODUCTS IN PROTEIN-FREE CULTURE
US6146873A (en) * 1994-11-10 2000-11-14 Baxter Aktiengesellschaft Production of orthomyxoviruses in monkey kidney cells using protein-free media
AU694592B2 (en) * 1994-11-16 1998-07-23 St. Jude Children's Research Hospital Novel replication process
DE19612967A1 (en) * 1996-04-01 1997-10-02 Behringwerke Ag Process for the propagation of influenza viruses in cell culture, and the influenza viruses obtainable by the process
DE19612966B4 (en) 1996-04-01 2009-12-10 Novartis Vaccines And Diagnostics Gmbh & Co. Kg MDCK cells and methods of propagating influenza viruses
DE10144906B4 (en) 2001-09-12 2013-11-28 Novartis Vaccines And Diagnostics Gmbh Process for the large-scale production of vaccines
US6830917B2 (en) 2001-12-10 2004-12-14 Baxter Healthcare S.A. Method of isolation and purification of trypsin from pronase protease and use thereof
AU2005314563B2 (en) 2004-11-03 2011-06-30 Seqirus UK Limited Influenza vaccination
US7883844B2 (en) 2006-05-11 2011-02-08 Juridical Foundation The Chemosero-Therapeutic Research Institute Method for propagating influenza virus
US8506966B2 (en) 2008-02-22 2013-08-13 Novartis Ag Adjuvanted influenza vaccines for pediatric use
TW201012930A (en) * 2008-06-16 2010-04-01 Intervet Int Bv Method of replicating viruses in suspension
DK2396032T3 (en) 2009-02-10 2016-12-19 Seqirus Uk Ltd Influenza vaccines with reduced amounts of squalene

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2262962B1 (en) * 1974-03-05 1977-11-04 Science Union & Cie

Also Published As

Publication number Publication date
ES8104405A1 (en) 1981-04-01
EP0019218A3 (en) 1981-03-25
EP0019218A2 (en) 1980-11-26
DK154749C (en) 1989-05-16
DE3071225D1 (en) 1985-12-19
YU41923B (en) 1988-02-29
YU126580A (en) 1983-12-31
AR220838A1 (en) 1980-11-28
DK212580A (en) 1980-11-16
DK154749B (en) 1988-12-19
NO801443L (en) 1980-11-17
RO79525B (en) 1984-09-30
JPH0124769B2 (en) 1989-05-15
JPS55153723A (en) 1980-11-29
ATE16454T1 (en) 1985-11-15
ES491517A0 (en) 1981-04-01
EP0019218B1 (en) 1985-11-13
IL60063A0 (en) 1980-07-31
EP0019218B2 (en) 1995-03-01
RO79525A (en) 1984-07-17
CA1122527A (en) 1982-04-27
AU5824480A (en) 1980-11-20

Similar Documents

Publication Publication Date Title
AU528776B2 (en) Pasteurellosis vaccines
AU520916B2 (en) Preparing liposomes
AU526537B2 (en) Combined methanol-ammonia production
AU523364B2 (en) Producing formcoke
AU5683680A (en) Synthetic influenza genes
AU535804B2 (en) Influenza vaccine production
AU529128B2 (en) Pneumonococcal vaccine
AU536158B2 (en) Diesterdiamides preparation
AU533653B2 (en) Novel mercaptoorganosiloxanes
AU530864B2 (en) Preparing lysergol derivatives
AU526422B2 (en) Producing isosorbide-5-nitrate
AU5463280A (en) Interferon production
AU518907B2 (en) Alumina production
AU522338B2 (en) Vaccine adjuvants
AU525504B2 (en) Intra-respiratory vaccine
AU536572B2 (en) Novel mercaptoorganopolysiloxanes
AU536177B2 (en) Preparing microcapsules
GB2048066B (en) Rabies vaccine
AU528999B2 (en) Preparing gypsum articles
AU518222B2 (en) Chloroacetanilides
AU535964B2 (en) Itanoxone preparation
AU534625B2 (en) Clostridal vaccine
AU530918B2 (en) Babesiosis vaccine
AU527659B2 (en) Anti-clostridiosis vaccine
AU530973B2 (en) Preparing cis-bicyclooctylamines

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired